Cervicogenic headache and onabotulinumtoxinA: where do we stand?
Cephalalgia
.
2011 Jul;31(9):979-80.
doi: 10.1177/0333102411410086.
Epub 2011 May 31.
Authors
W J Becker
,
P Chitsantikul
PMID:
21628434
DOI:
10.1177/0333102411410086
No abstract available
Publication types
Editorial
Comment
MeSH terms
Botulinum Toxins, Type A / therapeutic use*
Female
Humans
Male
Neuromuscular Agents / therapeutic use*
Post-Traumatic Headache / drug therapy*
Substances
Neuromuscular Agents
Botulinum Toxins, Type A